
APGE vs PCVX
$APGE vs $PCVX head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
APGE vs PCVX: trend, levels and the market
One year to 2026-09-02, against the S&P 500 (+14.4%). Split-adjusted daily closes.
- ·Both are in uptrends, trading above their 50- and 200-day averages, so this compares two names the market is already bidding up.
- ·Both beat the market over the past year: APGE +99.1% and PCVX +25%, against the S&P 500 at +14.4%.
- ·The last month has flipped the order: PCVX leads over the month (+12.6% against +0.7%) even though APGE leads over the year.
- ·APGE sits closer to its support, 0.5% above it at $134.40, while PCVX is 3.3% above its own at $53.89.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
APGE vs PCVX: the quick read
- ·APGE is the larger company by market cap ($10.18B vs $8.77B).
- ·PCVX has been more active on our scanner (101 vs 0 alerts in 30 days).
- ·APGE has the smaller float (75.3M vs 153.6M), which tends to mean sharper, more volatile moves.
- ·Both are biological products, (no diagnostic substances) names, so this is a like-for-like comparison and sector news tends to move them together.
- ·Only one of them shows up on our scanner: PCVX triggered 101 unusual-volume alerts in the last 30 days and the other triggered none.
- ·They are closely matched in size, within 16% of each other on market cap, which makes the rest of this table the interesting part.
Objective differences only. Not investment advice.
Watching APGE or PCVX? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing APGE and PCVX on TheDesperateTrader.
- Is APGE or PCVX the better stock?
- "Better" depends on your goal, and these two are not alike. APGE is the larger company by market cap ($10.18B vs $8.77B). PCVX has been more active on our scanner (101 vs 0 alerts in 30 days). APGE has the smaller float (75.3M vs 153.6M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between APGE and PCVX?
- The differences that matter: they are similar in size ($10.18B vs $8.77B); APGE sits at -81% of its 52-week range against 28% for PCVX; our scanner flagged APGE 0 times in the last 30 days against 101 for PCVX. Everything above is measured from the latest completed session and SEC filings.
- Which of APGE and PCVX is more active right now?
- Neither is showing unusual volume on the latest session, so nothing here is being driven by a volume spike. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is APGE or PCVX in the stronger trend?
- APGE is above its 50-day average of $134.13 and above its 200-day average of $91.97; PCVX is above its 50-day average of $57.89 and above its 200-day average of $53.93. APGE leads 3 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading APGE or PCVX? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.